You are here

News Center

May 10, 2017

Gladstone scientists uncovered a possible strategy to “shock and kill” the virus that hides in cells

April 27, 2017

Alexandra shares how her life-long interest in learning led her to graduate school and the pursuit of discovery in neuroscience.

April 28, 2017

Gladstone Stood Up for Science

April 27, 2017
Dr. Steve Finkbeiner

The funded program will, for the first time, introduce gene editing and stem cell therapies in the search for a potential cure

April 24, 2017

Gladstone scientists are the first to produce a type of stem cell–derived neuron that could potentially help restore movement

April 24, 2017

Gladstone scientists identify inflammatory pathways as a potential therapeutic target for frontotemporal dementia


April 12, 2017
Li Gan, PhD, Associate Director and Senior Investigator, Gladstone Institutes

Gladstone and UCSF scientists discover shared characteristic among neurodegenerative diseases that occur across the lifespan.

April 14, 2017

Scientists have developed sophisticated models to unravel complex human biology in their pursuit of cures.

April 7, 2017

Gladstone joined the national initiative that recognizes and celebrates the contributions, impact, and value of graduate students across all disciplines.

April 3, 2017
Dr. Steve Finkbeiner

Steven Finkbeiner was selected for the award based on his history of exceptional talent, imagination, and preeminent scientific achievement in finding better treatments for Huntington’s disease.

March 30, 2017

Jeremy Chang, a postdoctoral scholar at Gladstone, shares how graduate school provided him with valuable opportunities and was one of the greatest eras of his life.

March 30, 2017
Dr. Li Gan

Li Gan's innovative research and admirable mentorship led to her appointment as associate director of the Gladstone Institute of Neurological Disease.

March 21, 2017

The 2017 Quantitative Biosciences Institute Symposium brought together scientists from around the country to learn about cutting-edge research technology and approaches.

March 27, 2017

Gladstone scientists discovered how the ends of chromosomes protect mice from developing a human disease of aging.

March 20, 2017
Gladstone scientists combine expertise in Alzheimer’s research with legacy as leaders in stem cell technology

Gladstone scientists combine expertise in Alzheimer’s research with legacy as leaders in stem cell technology

March 15, 2017

Gladstone’s Bioinformatics Core is dedicated to providing expertise in data analysis and visualization to answer complex biological questions with Big Data. 

March 8, 2017

Gladstone’s community continues efforts to support and address the diverse, unique, and complex needs of women in the organization.

February 24, 2017

Yu Zhang, a postdoctoral scholar at Gladstone, shares how training at Gladstone has benefitted her both professionally and personally.

February 16, 2017

By identifying the role of common cells in connective tissue, Gladstone scientists discovered a new target to fight transmission of the virus.

February 8, 2017
Katherine Pollard, PhD, Director, Gladstone Insitutes

Katherine Pollard, PhD, director of the convergence science initiative at the Gladstone Institutes, has been selected as a Chan Zuckerberg Investigator.

February 8, 2017

A trio of Gladstone scientists are studying the basic biology of the heart to guide the discovery of new therapies for conditions such as congenital heart disease and heart failure.

February 6, 2017
Philanthropist and venture capitalist William K. Bowes, Jr.

Bay Area philanthropist leaves a legacy as a long-time friend and supporter of the Gladstone Institutes.

February 3, 2017

Bay Area scientists gathered to learn about the latest advances in mass spectrometry.

February 1, 2017

Gladstone scientists are mapping the connections and functions of brain cells to identify new drug targets to treat psychiatric disorders.

January 26, 2017
Dr. Katerina Akassoglou

The NINDS award provides longer-term support and increased flexibility to pursue innovative, high-risk research on neurological diseases.